Trinity Life Sciences, a leading commercial partner to the life sciences industry, announced the acquisition of BluePrint Research Group. The acquisition positions Trinity as a premier partner for commercially focused strategy, insights and analytics for the life sciences industry and solidifies its global presence.
Originally founded in 1996 as Trinity Partners, Trinity has since grown to a global team of advisors, technical experts, data integrators and technology innovators. Trinity’s range of products and solutions includes industry-leading benchmarking solutions, powered by TGaS Advisors.
Trinity’s approach is focused on its foundation of three: advisory services, insights & analytics, and technology. By seamlessly integrating each of these solutions, Trinity is able to meet the distinct needs of both emerging biotech firms and established pharmaceutical companies by providing comprehensive end-to-end analytical and strategic support to early stage companies, as well as tools and solutions for larger, more established life sciences clients.
BluePrint consults with healthcare companies to inform global brand commercialization efforts for the industry’s most innovative therapies and products, impacting and improving global health and wellness. BluePrint Research Group adds a London office to Trinity’s international presence as well as increases its current resources in India and the East and West Coasts of the U.S.
TRINITY, in 2019, acquired Bell Canyon Consulting to create a new combined offering that will address critical gaps in the market for improved data management and reporting. With the Bell Canyon acquisition, TRINITY is able to provide both technical knowledge and subject matter expertise, improving data transparency, quality and access.
Takeaway: Trinity focusing on developing client partnerships and an evidence-first approach to strategic decision-making